F1000Research · 2017 · 82 citations · 39 references
PharmacyBiotechnologyDrug DiscoveryMetabolic EngineeringNatural Product BiosynthesisBiocatalyst DiscoveryCombinatorial BiosynthesisMetabolic Pathway EngineeringPathway EngineeringPolyketide BiosynthesisGenome MiningGenome Mining For Natural ProductsPolyketide Synthase EngineeringPolyketide Synthase PathwaysType Ii Polyketide Synthases
Bacterial aromatic polyketides, exemplified by anthracyclines, angucyclines, tetracyclines, and pentangular polyphenols, are a large family of natural products with diverse structures and biological activities and are usually biosynthesized by type II polyketide synthases (PKSs). Since the starting point of biosynthesis and combinatorial biosynthesis in 1984-1985, there has been a continuous effort to investigate the biosynthetic logic of aromatic polyketides owing to the urgent need of developing promising therapeutic candidates from these compounds. Recently, significant advances in the structural and mechanistic identification of enzymes involved in aromatic polyketide biosynthesis have been made on the basis of novel genetic, biochemical, and chemical technologies. This review highlights the progress in bacterial type II PKSs in the past three years (2013-2016). Moreover, novel compounds discovered or created by genome mining and biosynthetic engineering are also included.
39
Flavin-mediated dual oxidation controls an enzymatic Favorskii-type rearrangement
Robin Teufel, Akimasa Miyanaga, Quentin Michaudel et al. · Nature · 2013 · 180 citations
Co-opting sulphur-carrier proteins from primary metabolic pathways for 2-thiosugar biosynthesis
Eita Sasaki, Xuan Zhang, He Sun et al. · Nature · 2014 · 74 citations · Full text